Mariner’s Ascendis Pharma A/S ASND Stock Holding History

Mariner’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$936K	Buy	3,509 +957	+38%	+$224K	﹤0.01%	2001
2026 Q1	$583K	Sell	2,552 -16	-0.6%	-$3.59K	﹤0.01%	2375
2025 Q4	$548K	Buy	2,568 +502	+24%	+$104K	﹤0.01%	2382
2025 Q3	$411K	Buy	2,066 +273	+15%	+$50.9K	﹤0.01%	2582
2025 Q2	$309K	Sell	1,793 -110	-6%	-$17.9K	﹤0.01%	2706
2025 Q1	$297K	Sell	1,903 -257	-12%	-$36.7K	﹤0.01%	2634
2024 Q4	$297K	Buy	2,160 +511	+31%	+$67.2K	﹤0.01%	2627
2024 Q3	$245K	Buy	1,649 +25	+2%	+$3.38K	﹤0.01%	2754
2024 Q2	$221K	Sell	1,624 -62	-4%	-$8.44K	﹤0.01%	2704
2024 Q1	$255K	Buy	+1,686	New	+$241K	﹤0.01%	2578

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mariner's ASND Position: Q2 2026 in Review

Mariner increased its Ascendis Pharma A/S (ASND) stake by 38% in Q2 2026, buying an estimated $224K and bringing the position to 3,509 shares worth $936K. The position accounts for ﹤0.01% of the portfolio, ranked #2001.

Mariner first reported a position in ASND in Q1 2024 and has held it in 10 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Mariner held 3,509 shares of Ascendis Pharma A/S worth $936K as of Q2 2026.
Mariner bought 957 Ascendis Pharma A/S shares in Q2 2026, an estimated $224K.
Ascendis Pharma A/S made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2001 holding.
Mariner first reported a position in Ascendis Pharma A/S in Q1 2024 and has held it in 10 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.